Description:

ODM derived from http://clinicaltrials.gov/show/NCT00518895

Link:

http://clinicaltrials.gov/show/NCT00518895

Keywords:
Versions (2) ▾
  1. 12/10/13
  2. 4/14/14
Uploaded on:

April 14, 2014

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility DRKS00003621 NCT00518895 Melanoma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age at least 18 Years
Histologically confirmed diagnosis of melanoma
Progressive disease that is not surgically resectable, or metastatic Stage IV
Low-normal LDH, defined as <= 0.8 times the upper limit of normal
No prior chemotherapy
Measurable Disease
ECOG performance status finding <= 1
At least 4 weeks and recovery from effects of major prior surgery or other therapy, including immunotherapy, radiation therapy, or cytokine, biologic or vaccine therapy
Prior immunotherapy allowed
Adequate organ function
Exclusion Criteria
Prior cytotoxic chemotherapy, including regional perfusion, or prior Genasense treatment
Primary ocular or mucosal melanoma
Metastatic Malignant Neoplasm to the Bone
History or presence of brain metastasis or leptomeningeal disease
Significant medical disease other than cancer
Organ allograft